Anifrolumab treatment is linked to improved disease activity and reduced steroid use and has an acceptable safety profile in routine care of patients with systemic lupus erythematosus.
Tasting Table on MSN
A massive KitKat heist just hit Europe — and the missing bars aren't ordinary
In a surprise turn of events, thousands of KitKat bars have gone missing somewhere between Central Italy and Poland — and ...
Your hormones can impact your oral health, but a dentist explains the simple habits that can help ...
US biotech Biogen has announced positive results from the Phase II part of the AMETHYST Phase II/III study (Part A) of litifilimab in people living with cutaneous lupus erythematosus (CLE).
For tens of thousands of children worldwide, idiopathic nephrotic syndrome (INS), a chronic and debilitating kidney disease, ...
The DWP has confirmed 178 conditions eligible for Personal Independence Payment ...
The DWP has confirmed 178 conditions eligible for Personal Independence Payments, or PIP.
Planet Rugby on MSN
Who’s hot and who’s not: Saints ‘box clever’ with Henry Pollock, ‘minnows lighting up’ URC and Geoff Parling ‘turns the air blue’
It’s time for our Monday wrap of who has their name in lights and who is making the headlines for all the wrong reasons after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results